Serum levels of brain‐derived neurotrophic factor in remission, but not the acute phase, may predict the development from depression to dementia

Abstract

AbstractObjectivesDepression may be a risk factor or a prodromal symptom of dementia, and decreased serum levels of brain‐derived neurotrophic factor (BDNF) have been observed in both depression and dementia. The aim of the present study was to determine whether serum levels of BDNF in the remitted or acute phase of depression predicted the transition from depression to dementia.MethodsSerum levels of BDNF were measured in the acute phase of depression (n = 204) and after remission (n = 117), and we followed (mean: 24.3 months) the participants to assess the subsequent onset of dementia or mild cognitive impairment (MCI).ResultsSerum levels of BDNF after remission, but not those in the acute depressive phase, predicted the future development of dementia or MCI.ConclusionsPatients with low serum BDNF levels, even after depression remission, might have an increased risk of developing dementia. These findings suggest a potential association between residual low serum BDNF levels after remission and the prodromal state of dementia, or the involvement of BDNF in the transition from depression to dementia. However, given that this study is low‐powered and preliminary, interpretation of the results should be approached with caution.